the Thai Food and Drug Administration (

In strategic partnership with Pharco Pharmaceuticals .. Ravidasvir receives approval in Thailand for the treatment of Hepatitis C

 In a historic step for the Egyptian pharmaceutical industry that reinforces its global leadership, the Thai Food and Drug Administration (Thai FDA) has officially approved Ravidasvir as a safe and effective treatment against the hepatitis C virus (HCV). This approval is part of a robust clinical and regulatory ecosystem spearheaded by the Thai FDA, organically linked with the Government Pharmaceutical…